IRISanRaf

STOCCHI, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.526
AS - Asia 3.836
EU - Europa 559
Continente sconosciuto - Info sul continente non disponibili 110
OC - Oceania 16
SA - Sud America 11
AF - Africa 2
Totale 10.060
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.765
TR - Turchia 2.031
SG - Singapore 947
CN - Cina 766
CA - Canada 760
IT - Italia 210
EU - Europa 110
DE - Germania 92
IE - Irlanda 76
UA - Ucraina 42
HK - Hong Kong 27
IN - India 23
RU - Federazione Russa 22
FI - Finlandia 21
GB - Regno Unito 21
FR - Francia 18
JP - Giappone 15
NL - Olanda 12
KR - Corea 11
AU - Australia 10
GR - Grecia 10
BR - Brasile 9
RO - Romania 8
IL - Israele 7
NZ - Nuova Zelanda 6
SI - Slovenia 6
SE - Svezia 5
ES - Italia 4
TH - Thailandia 4
CH - Svizzera 3
DK - Danimarca 2
PL - Polonia 2
TW - Taiwan 2
AT - Austria 1
BD - Bangladesh 1
BG - Bulgaria 1
CO - Colombia 1
CZ - Repubblica Ceca 1
EG - Egitto 1
LU - Lussemburgo 1
MK - Macedonia 1
MX - Messico 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
ZA - Sudafrica 1
Totale 10.060
Salva come PNG Salva come JPEG
Città #
Kocaeli 1.743
San Mateo 1.283
Toronto 752
Chandler 392
Houston 381
Wilmington 373
Santa Clara 352
Singapore 284
Lawrence 249
Princeton 249
Beijing 155
Fairfield 151
Ashburn 137
Woodbridge 87
Seattle 76
Los Angeles 71
Shanghai 69
Guangzhou 61
Cambridge 33
Shenzhen 33
Rome 31
Dublin 29
Hong Kong 26
Milan 23
Wuhan 19
Helsinki 18
Jiaxing 18
Rui'an 18
Assago 16
Dallas 16
Boardman 15
Xi'an 11
Quanzhou 10
Redwood City 9
Wuxi 9
Xuzhou 9
West Jordan 8
Andover 7
Brooklyn 7
Frankfurt am Main 7
Nanjing 7
Pune 7
Redmond 7
Solagna 7
Boston 6
Kyiv 6
St Petersburg 6
Timisoara 6
Washington 6
Dongyang 5
Florence 5
Melbourne 5
Moscow 5
Munich 5
Rockville 5
Auckland 4
Bologna 4
Chiang Mai 4
Clifton 4
Ljubljana 4
Minoh 4
Montegabbione 4
Nocera Inferiore 4
Qingdao 4
Seoul 4
Sydney 4
Taizhou 4
Tokyo 4
Yeonsu-gu 4
Aparecida de Goiania 3
Austin 3
Camarillo 3
Chengdu 3
Cisterna di Latina 3
Gatchina 3
Genova 3
Giresun 3
Haining 3
Jinan 3
Mumbai 3
Napoli 3
Ningbo 3
Norwalk 3
Parker 3
Southwark 3
Tel Aviv 3
Tianjin 3
Weitang 3
Wuhu 3
Auburn 2
Benedikt 2
Borås 2
Certaldo 2
Chennai 2
Chioggia 2
Cork 2
Des Moines 2
Espoo 2
Giussano 2
Hefei 2
Totale 7.463
Salva come PNG Salva come JPEG
Nome #
Morbo di Parkinson: strategie terapeutiche e qualità della vita del malato 94
A Systems Medicine Clinical Platform for Understanding and Managing Non-Communicable Diseases 85
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on qualità of life in Parkinson’s disease 72
L’alimentazione del paziente parkinsoniano 66
Apomorphine and lisuride infusion. A comparative chronic study 61
A pharmacological study of dopaminergic receptors in planaria 59
Gastrointestinal dysfunction in Parkinson's disease 58
Side-effects of subcutaneous apomorphine in Parkinson's disease 58
Modification of respiratory function parameters in patients with severe Parkinson's disease 57
Acute Modulation of Brain Connectivity in Parkinson Disease after Automatic Mechanical Peripheral Stimulation: A Pilot Study 55
Adherence to antiparkinson medication in a multicenter European study 54
One year treatment with lisuride delivery pump in Parkinson's disease 54
Neuroprotection in Parkinson's disease: clinical trials 53
Continuous apomorphine infusion and neuropsychiatric disorders: a controlled study in patients with advanced Parkinson's disease 52
Robot-assisted gait training versus treadmill training in patients with Parkinson's disease: a kinematic evaluation with gait profile score Epub 2016 52
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor 52
Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 52
Advances in Alzheimer's and Parkinson's Disease: Insights, Progress, and Perspectives 51
Case Study 10 49
Transient left bundle branch block following intravenous lisuride bolus 49
Managing the critical problems of advanced Parkinson's disease 49
A toxin injection in patients with blepharospasm, torticollis and hemifacial spasm 49
Analyzing gait variability and dual-task interference in patients with Parkinson's disease and freezing by means of the word-color Stroop test 49
Transient atrial fibrillation after subcutaneous apomorphine bolus 49
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease 49
Levodopa: A new look at an old friend 48
Clinical Experiences With Levodopa Methylester (Melevodopa) in Patients With Parkinson Disease Experiencing Motor Fluctuations: An Open-Label Observational Study 48
The coefficient of friction in Parkinson's disease gait 48
Corneal and blink reflexes in Parkinson's disease with "on-off" fluctuations 47
Clinical efficacy of a single afternoon dose of effervescent levodopa-carbidopa preparation (CHF 1512) in fluctuating Parkinson disease 47
The clinical efficacy of single morning doses of levodopa methyl ester: dispersible Madopar and Sinemet plus in Parkinson disease 47
White matter disease (Binswanger's encephalopathy) in chronic cerebrovascular disorders 47
Unusual cardiovascular response to intravenous lisuride bolus. Possible drug-induced coronary angiospasm 47
The pharmacokinetic profile of levodopa administered with and without tolcapone in patients with advanced PD 47
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia 47
Antagonist effect of terguride in Parkinson's disease 46
Constipation in Parkinson's Disease 46
Comparison between L-dopa and lisuride intravenous infusions: a clinical study 46
Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 46
Management of gastrointestinal alterations in Parkinson's disease 45
Jejunal delivery of levodopa methyl ester 45
Multicenter trial of L-Deprenyl in Parkinson disease 45
Single-dose studies of a slow-release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease 45
Instrumental diagnosis of multiple system atrophy 44
Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations 44
A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients 44
Effects of terguride in patients with Huntington's disease 44
Combination of two different dopamine agonists in the management of Parkinson's disease 44
The clinical efficacy of oral levodopa methyl ester solution in reversing afternoon "off" periods in Parkinson's disease 44
On-off phenomena in Parkinson's disease. Continuous dopaminergic stimulation 44
The Bereitschaftspotential preceding simple foot movement and initiation of gait in Parkinson's disease 44
Continuous dopamine-receptor stimulation in advanced Parkinson's disease 44
Parkinson's Disease: Non-motor and non-dopaminergic Features 43
Cohort study of prevalence and phenomenology of tremor in dementia with Lewy bodies 43
An open study with reversible MAO-A inhibitors in complicated Parkinson's disease 43
trategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias 43
Use of Apomorphine in Parkinson’s Disease 43
Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder 43
Optimising levodopa therapy for the management of Parkinson's disease 43
Repeated levodopa infusions in fluctuating Parkinson's disease: clinical and pharmacokinetic data 43
Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results 43
Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study 43
Emergencies in Parkinson's disease 42
Transient cardiac arrest during continuous intravenous infusion of apomorphine 42
The therapeutic concept of continuous dopaminergic stimulation (CDS) in the treatment of Parkinson’s disease 42
A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease 42
Novel parkin mutations detected in patients with early-onset Parkinson's disease 42
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients 42
GIGYF2 mutations are not frequent cause of familiar Parkinson’s disease 42
Benefits of treatment with rasagiline for fatigue symptoms in patients with early Parkinson's disease 42
Urodynamic study in the differential diagnosis between multiple system atrophy and Parkinson's disease 42
Increased expression of dopamine receptors on lymphocytes in Parkinson's disease 42
A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need 42
Gastrointestinal, urological, and sleep problems in parkinson's disease 41
Malattie Extrapiramidali: aspetti clinici e terapeutici nelle sindromi parkinsoniane 41
A double-blind, delayed-start trial of rasagiline in Parkinson’s disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes 41
Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease 41
Determination of apomorphine in human plasma by alumina extraction and high-performance liquid chromatography with electrochemical detection 41
Urodynamic and neurophysiological evaluation in Parkinson's disease and multiple system atrophy 41
Dual dopamine agonist treatment in Parkinson's disease 41
Prevention and treatment of motor fluctuations 41
Motor fluctuations in levodopa treatment: clinical pharmacology 41
A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism 41
Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment 41
Farmaci Antiparkinsoniani 41
Validation of the freezing of gait questionnaire in patients with Parkinson's disease 40
An appraisal of the problem of dementia in Parkinson's disease 40
Clinical implications of sustained dopaminergic stimulation. 40
Effects of robot assisted gait training in progressive supranuclear palsy (PSP): a preliminary report 40
A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics 40
Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease 40
Wearing-off scales in Parkinson's disease: Critique and recommendations 40
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial 40
The effect of steady-state ropinirole on plasma concentrations of digoxin in patients with Parkinson's disease 40
Long-term effects of automated mechanical peripheral stimulation on gait patterns of patients with Parkinson's disease 40
Timed Up and Go test and wearable inertial sensor: a new combining tool to assess change in subject with Parkinson’s disease after automated mechanical peripheral stimulation treatment 40
Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease 40
Alterations of thermoregulation in Parkinson's disease 40
A double-blind, delayed-start trial of rasagiline in Parkinson’s disease 40
Intermittent vs continuous levodopa administration in patients with advanced Parkinson disease: a clinical and pharmacokinetic study 39
Totale 4.644
Salva come PNG Salva come JPEG
Categoria #
all - tutte 112.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.768
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020211 0 0 0 0 0 0 0 0 0 0 77 134
2020/20212.683 146 134 36 8 44 170 83 39 63 47 1.746 167
2021/20222.486 11 761 758 9 6 1 209 281 18 351 6 75
2022/20231.298 561 35 12 118 83 31 2 86 93 113 160 4
2023/20241.031 4 19 81 243 50 45 15 60 13 87 26 388
2024/20252.204 127 591 159 126 95 387 118 185 389 24 3 0
Totale 10.468